These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 8689285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of a new solid formulation of calcium and vitamin D in institutionalized elderly subjects. A randomized comparative trial versus separate administration of both constituents.
    Sebert JL, Garabedian M, Chauvenet M, Maamer M, Agbomson F, Brazier M.
    Rev Rhum Engl Ed; 1995 Apr; 62(4):288-94. PubMed ID: 7606425
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence and biological consequences of vitamin D deficiency in elderly institutionalized subjects.
    Fardellone P, Sebert JL, Garabedian M, Bellony R, Maamer M, Agbomson F, Brazier M.
    Rev Rhum Engl Ed; 1995 Oct; 62(9):576-81. PubMed ID: 8574630
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of daily calcium and vitamin D supplementation on parathyroid hormone secretion.
    Reginster JY, Zegels B, Lejeune E, Micheletti MC, Taquet AN, Albert A.
    Gynecol Endocrinol; 2001 Feb; 15(1):56-62. PubMed ID: 11293926
    [Abstract] [Full Text] [Related]

  • 8. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
    Lindberg J, Martin KJ, González EA, Acchiardo SR, Valdin JR, Soltanek C.
    Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D, Byham-Gray L, Lewis E, McCaffrey S.
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [Abstract] [Full Text] [Related]

  • 10. Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study.
    Brazier M, Grados F, Kamel S, Mathieu M, Morel A, Maamer M, Sebert JL, Fardellone P.
    Clin Ther; 2005 Dec; 27(12):1885-93. PubMed ID: 16507374
    [Abstract] [Full Text] [Related]

  • 11. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
    Soliman AT, Al Khalaf F, Alhemaidi N, Al Ali M, Al Zyoud M, Yakoot K.
    Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
    Beyer TD, Solorzano CC, Prinz RA, Babu A, Nilubol N, Patel S.
    Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High prevalence of vitamin D deficiency among Ethiopian women immigrants to Israel: exacerbation during pregnancy and lactation.
    Fogelman Y, Rakover Y, Luboshitzky R.
    Isr J Med Sci; 1995 Apr; 31(4):221-4. PubMed ID: 7721559
    [Abstract] [Full Text] [Related]

  • 17. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia.
    Collins N, Maher J, Cole M, Baker M, Callaghan N.
    Q J Med; 1991 Feb; 78(286):113-22. PubMed ID: 1851568
    [Abstract] [Full Text] [Related]

  • 18. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL, Hristova M, Ho LT, Sprague SM.
    Am J Nephrol; 2007 Feb; 27(1):36-43. PubMed ID: 17215573
    [Abstract] [Full Text] [Related]

  • 19. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [Abstract] [Full Text] [Related]

  • 20. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER, Kovacs KA, Jones G.
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.